Molecular mechanisms of cefoxitin resistance in Escherichia coli from the Toronto area hospitals
- 1 September 2001
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 41 (1-2) , 57-63
- https://doi.org/10.1016/s0732-8893(01)00278-4
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- A Novel Type of AmpC β-Lactamase, ACC-1, Produced by a Klebsiella pneumoniae Strain Causing Nosocomial PneumoniaAntimicrobial Agents and Chemotherapy, 1999
- Molecular Basis of AmpC Hyperproduction in Clinical Isolates of Escherichia coliAntimicrobial Agents and Chemotherapy, 1999
- Transferable class C beta-lactamases in Escherichia coli strains isolated in Greek hospitals and characterization of two enzyme variants (LAT-3 and LAT-4) closely related to Citrobacter freundii AmpC beta-lactamase.Journal of Antimicrobial Chemotherapy, 1998
- Transcontinental importation into the UK of Escherichia coli expressing a plasmid-mediated AmpC-type beta-lactamase exposed during an outbreak of SHV-5 extended-spectrum beta-lactamase in a Leeds hospital.Journal of Antimicrobial Chemotherapy, 1997
- EXTENDED-SPECTRUM β-LACTAMASES AND OTHER ENZYMES PROVIDING RESISTANCE TO OXYIMINO-β-LACTAMSInfectious Disease Clinics of North America, 1997
- Inhibitor-resistant TEM (IRT) beta-lactamases with different substitutions at position 244Antimicrobial Agents and Chemotherapy, 1997
- [2] Escherichia coli promoter sequences: Analysis and predictionPublished by Elsevier ,1996
- Compilation ofE.colimRNA promoter sequencesNucleic Acids Research, 1993
- Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniaeAntimicrobial Agents and Chemotherapy, 1990
- The E. coli β-lactamase attenuator mediates growth rate-dependent regulationNature, 1981